Lv4
588 积分 2022-06-14 加入
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2天前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
3天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
5天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
A guide to adaptive immune memory
1个月前
已完结
Presetting CAR-T cells during ex vivo biomanufacturing
1个月前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
1个月前
已完结
BVX001, a Bispecific ADC Targeting CD7-Positive AML with Favorable Toxicity Profile, Exhibits Significant Efficacy in Primary Patient Samples and PDX-Models
3个月前
已完结
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
3个月前
已完结
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
3个月前
已完结
皖公网安备34019202002308
